GlassScriptPhysician profile
Steven T Adelstein
NPI 1518961424
$8,297.29
in general payments reported to CMS, 2019-2025
33 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $490 · 2021: $658 · 2022: $908 · 2023: $2,945 · 2024: $1,274 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,901 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,900.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,632.77 | 2019-2025 | Grafix Pl, Stravix, Grafix |
| Organogenesis INC. | $1,225.54 | 2019-2025 | Affinity, Puraply, Apligraf |
| Kerecis Limited | $534.53 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Inari Medical, INC. | $371.93 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surgenex LLC | $243.60 | 2025 | Ardeograft, Renograft, Surmatrix |
| Kci USA, INC. | $238.62 | 2019 | |
| Urgo Medical North America, LLC | $229.64 | 2022-2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Mimedx Group, INC. | $176.95 | 2024 | |
| Ets Wound Care LLC | $161.72 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Osiris Therapeutics INC. | $142.63 | 2019 | |
| Acera Surgical, INC. | $140.80 | 2021-2023 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $124.92 | 2019-2021 | |
| Paragon 28, INC. | $99.04 | 2023-2025 | Bun-Yo-Matic, Portfolio, Phantom Metatarsal Shortening |
| Zimmer Biomet Holdings, INC. | $97.21 | 2020-2023 | Allograft |
| Stryker Corporation | $88.57 | 2023-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Actishield |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $76.41 | 2024-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $74.58 | 2022-2023 | Orbactiv, Kimyrsa |
| Integra Lifesciences Corporation | $68.34 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $67.65 | 2024-2025 | |
| Misonix INC | $61.15 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.57 | 2020-2023 | Jublia |
| Next Science LLC | $48.21 | 2023 | Xperience, Blastx, Surgx |
| Aroa Biosurgery Incorporated | $47.35 | 2022-2024 | |
| Abbott Laboratories | $46.75 | 2019-2020 | |
| Solventum Corporation | $43.87 | 2024-2025 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Sebela Pharmaceuticals INC. | $36.72 | 2020-2021 | |
| Depuy Synthes Sales INC. | $33.52 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $30.88 | 2025 | |
| Tactile Systems Technology INC | $27.11 | 2019-2020 | |
| Nevro Corp. | $26.96 | 2023 | Senza |
| Kowa Pharmaceuticals America, INC. | $16.76 | 2023 | Seglentis |
| Wright Medical Technology, INC. | $14.95 | 2019 | |
| Bioventus LLC | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Adelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.